2.7.1.113	1,2-Cyclohexanedione	-	2324	
2.7.1.113	1-alpha-D-arabinofuranosylguanine	-	51229	
2.7.1.113	2,3-Butanedione	-	1001	
2.7.1.113	2-fluoro-9-beta-D-arabinofuranosyladenine	-	56736	
2.7.1.113	8-aza-2'-deoxyguanosine	-	51475	
2.7.1.113	8-azadeoxyguanosine	-	92123	
2.7.1.113	9-beta-D-arabinofuranosylguanine	-	8481	
2.7.1.113	ADP	1 mM, 45% inhibition at pH 6.0	13	
2.7.1.113	ADP	-	13	
2.7.1.113	AMP	weak inhibition	30	
2.7.1.113	arabinoadenosine	-	43780	
2.7.1.113	arabinocytidine	-	92471	
2.7.1.113	arabinosylguanine	-	43782	
2.7.1.113	ATP	weak inhibition	4	
2.7.1.113	carbodiimide	-	5948	
2.7.1.113	cladribine	-	5796	
2.7.1.113	clofarabine	-	5855	
2.7.1.113	CMP	weak inhibition	100	
2.7.1.113	CTP	-	60	
2.7.1.113	CuSO4	-	263	
2.7.1.113	cytarabine	-	35304	
2.7.1.113	dADP	1 mM, 49% inhibition at pH 6.0	731	
2.7.1.113	dAMP	-	716	
2.7.1.113	dATP	0.1 mM, 62% inhibition	140	
2.7.1.113	dATP	1 mM, 71% inhibition at pH 6.0	140	
2.7.1.113	dATP	-	140	
2.7.1.113	dATP	feedback inhibition	140	
2.7.1.113	dCDP	-	1124	
2.7.1.113	dCMP	weak inhibition	450	
2.7.1.113	dCTP	0.1 mM, 48% inhibition	179	
2.7.1.113	dCTP	-	179	
2.7.1.113	deoxyadenosine	0.07 mM, 9% inhibition	601	
2.7.1.113	deoxyadenosine	weak inhibition	601	
2.7.1.113	deoxyadenosine	-	601	
2.7.1.113	deoxyinosine	0.07 mM, 17% inhibition	1104	
2.7.1.113	deoxyinosine	-	1104	
2.7.1.113	dGDP	0.1 mM, 97% inhibition	1140	
2.7.1.113	dGDP	0.1 mM, 55% inhibition	1140	
2.7.1.113	dGDP	0.0021 mM, 50% inhibition, reversed by 0.2 mM dTTP	1140	
2.7.1.113	dGDP	-	1140	
2.7.1.113	dGMP	-	729	
2.7.1.113	dGMP	very weak inhibition	729	
2.7.1.113	dGMP	0.1 mM, 44% inhibition	729	
2.7.1.113	dGMP	1 mM, 64% inhibition at pH 6.0	729	
2.7.1.113	dGMP	noncompetitive versus UTP and 2'-deoxyguanosine	729	
2.7.1.113	dGTP	0.1 mM, 99% inhibition	219	
2.7.1.113	dGTP	1 mM, 96% inhibition	219	
2.7.1.113	dGTP	0.1 mM, complete inhibition	219	
2.7.1.113	dGTP	0.001 mM, 50% inhibition, 1 mM, complete inhibition, reversed by 0.2 mM dTTP	219	
2.7.1.113	dGTP	-	219	
2.7.1.113	dGTP	0.5 mM, 95% of recombinant dGK	219	
2.7.1.113	dGTP	feedback inhibition	219	
2.7.1.113	dIMP	-	3813	
2.7.1.113	diphosphate	competitive inhibition	17	
2.7.1.113	dITP	0.1 mM, 65% inhibition	2839	
2.7.1.113	dITP	-	2839	
2.7.1.113	dTDP	-	542	
2.7.1.113	dTDP	1 mM, 51% inhibition at pH 6.0	542	
2.7.1.113	dTMP	weak inhibition	635	
2.7.1.113	dTTP	0.1 mM, 30% inhibition	145	
2.7.1.113	dUTP	-	435	
2.7.1.113	EDTA	-	21	
2.7.1.113	ethoxyformic anhydride	deoxyguanosine slightly protects	9161	
2.7.1.113	GDP	1 mM, 50% inhibition at pH 6.0	53	
2.7.1.113	gemcitabine	-	1899	
2.7.1.113	GMP	weak inhibition	162	
2.7.1.113	GTP	0.1 mM, 33% inhibition	37	
2.7.1.113	GTP	-	37	
2.7.1.113	guanosine	-	296	
2.7.1.113	IDP	1 mM, 58% inhibition at pH 6.0	444	
2.7.1.113	Iodine	-	1619	
2.7.1.113	additional information	not inhibited by deoxyadenosine	2	
2.7.1.113	additional information	not inhibited by dADP; not inhibited by dATP; not inhibited by dCTP; not inhibited by GTP	2	
2.7.1.113	additional information	not inhibited by acyclovir, 6-thiodeoxyguanosine, methylacetimidate, pyridoxal phosphate; not inhibited by deoxyadenosine; not inhibited by deoxycytidine, adenosine; not inhibited by guanosine	2	
2.7.1.113	additional information	not inhibited by dAMP	2	
2.7.1.113	additional information	not inhibited by deoxycytidine, adenosine; not inhibited by dTTP; not inhibited by inosine, cytidine, uridine, deoxythymidine, deoxyuridine	2	
2.7.1.113	additional information	no substrate inhibition by CTP, ATP, and GTP	2	
2.7.1.113	N-ethylmaleimide	-	49	
2.7.1.113	p-mercuribenzoate	-	686	
2.7.1.113	ribavirin	-	1304	
2.7.1.113	Rose Bengal mediated photooxidation	deoxyguanosine protects	98324	
2.7.1.113	UDP	strong inhibition	26	
2.7.1.113	UDP	competitive versus UTP, noncompetitive versus 2'-deoxyguanosine	26	
2.7.1.113	UMP	0.1 mM, 24% inhibition	133	
2.7.1.113	UTP	0.1 mM, 30% inhibition	65	
2.7.1.113	UTP	-	65	
2.7.1.113	UTP	substrate inhibition, overview	65